Skip to main content
Year archive

CSPC Pharmaceutical Group Limited — 2021 filings

All 104 regulatory filings released by CSPC Pharmaceutical Group Limited (1093) in 2021, sourced directly from the official regulator.

104 Filings
2021 Period
2021 filings (104)
Filing Released Lang
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-31 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-30 English
VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE PRMT5 INHIBITOR "SYHX2001" OBTAINS CLINICAL TRIAL APPROVAL
Regulatory Filings
2021-12-29 English
SUPPLEMENTAL ANNOUNCEMENT RELATING TO THE RENEWED LEASE AGREEMENTS
Capital/Financing Update
2021-12-29 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-29 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-28 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-24 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-23 English
CONNECTED TRANSACTIONS - RENEWAL OF LEASE AGREEMENTS
Regulatory Filings
2021-12-22 English
CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF MASTER PURCHASE AGREEMENT
Regulatory Filings
2021-12-22 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-14 English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE 1/2 CLINICAL TRIAL OF JMT601 IN THE U.S.
Regulatory Filings
2021-12-14 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-13 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-10 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-08 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-07 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-06 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-03 English
VOLUNTARY ANNOUNCEMENT - INCLUSION OF ANFULIKE IN THE NATIONAL REIMBURSEMENT DRUG LIST
Regulatory Filings
2021-12-03 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-02 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2021
Regulatory Filings
2021-12-01 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-11-30 English
CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF MASTER SALES AGREEMENT
Regulatory Filings
2021-11-22 English
VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT WITH KEYMED BIOSCIENCE (CHENGDU) CO., LTD. FOR CM326
Regulatory Filings
2021-11-22 English
QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2021
Interim / Quarterly Report
2021-11-18 English
DATE OF BOARD MEETING
Regulatory Filings
2021-11-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2021
Regulatory Filings
2021-11-01 English
INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THIRD QUARTER OF 2021
Interim / Quarterly Report
2021-10-21 English
REVISION OF ANNUAL CAP FOR CONTINUING CONNECTED TRANSACTIONS
Capital/Financing Update
2021-10-21 English
VOLUNTARY ANNOUNCEMENT - "APIXABAN TABLETS" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2021-10-15 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2021
Regulatory Filings
2021-10-04 English
REVISION OF ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS
Regulatory Filings
2021-09-30 English
VOLUNTARY ANNOUNCEMENT - STRATEGIC ALLIANCE AGREEMENT WITH KEYMED BIOSCIENCE (CHENGDU) CO., LTD
Regulatory Filings
2021-09-23 English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS: NOTICE OF PUBLICATION OF 2021 INTERIM REPORT
Report Publication Announcement
2021-09-16 English
INTERIM REPORT 2021
Regulatory Filings
2021-09-16 English
VOLUNTARY ANNOUNCEMENT - NBL-015 OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Regulatory Filings
2021-09-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2021
Regulatory Filings
2021-09-02 English
VOLUNTARY ANNOUNCEMENT - "OSELTAMIVIR PHOSPHATE CAPSULES" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2021-09-01 English
2021 INTERIM DIVIDEND
Notice of Dividend Amount
2021-08-26 English
2021 INTERIM RESULTS ANNOUNCEMENT
Interim / Quarterly Report
2021-08-26 English
VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT WITH JIANGSU ALPHAMAB FOR THE DEVELOPMENT AND COMMERCIALIZATION OF KN026 IN CHINA
Capital/Financing Update
2021-08-23 English
INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE HALF YEAR ENDED 30 JUNE 2021
Interim / Quarterly Report
2021-08-19 English
VOLUNTARY ANNOUNCEMENT - STRATEGIC PARTNERSHIP AND LICENSE AGREEMENT WITH FLAME BIOSCIENCES
Capital/Financing Update
2021-08-17 English
DATE OF BOARD MEETING
Regulatory Filings
2021-08-16 English
VOLUNTARY ANNOUNCEMENT - "AFATINIB DIMALEATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2021-08-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2021
Regulatory Filings
2021-08-04 English
VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE "SYSA1801" OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.
Regulatory Filings
2021-07-16 English
2020 CORPORATE SOCIAL RESPONSIBILITY REPORT
Regulatory Filings
2021-07-05 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2021
Regulatory Filings
2021-07-02 English
VOLUNTARY ANNOUNCEMENT - "TOFACITINIB CITRATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2021-06-25 English
VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE "SYSA1801" OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Regulatory Filings
2021-06-16 English
VOLUNTARY ANNOUNCEMENT - ANTI-TUMOR NANODRUG "SIROLIMUS FOR INJECTION (ALBUMIN-BOUND)" OBTAINS CLINICAL TRIAL APPROVAL
Regulatory Filings
2021-06-09 English
VOLUNTARY ANNOUNCEMENT - "PREGABALIN CAPSULES" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2021-06-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2021
Regulatory Filings
2021-06-01 English
VOLUNTARY ANNOUNCEMENT - "LACOSAMIDE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2021-05-31 English
VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE CDK9 INHIBITOR "SYHX1903" OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Regulatory Filings
2021-05-25 English
VOLUNTARY ANNOUNCEMENT - "LINAGLIPTIN TABLETS" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2021-05-25 English
VOLUNTARY ANNOUNCEMENT - NBL-015 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.
Regulatory Filings
2021-05-25 English
QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2021
Interim / Quarterly Report
2021-05-24 English
VOLUNTARY ANNOUNCEMENT - INNOVATIVE DRUG "SYHA1811 TABLETS" OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Regulatory Filings
2021-05-20 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 18 MAY 2021
Declaration of Voting Results & Voting Rights Announcements
2021-05-18 English
DATE OF BOARD MEETING
Regulatory Filings
2021-05-11 English
VOLUNTARY ANNOUNCEMENT - "SITAGLIPTIN PHOSPHATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2021-05-11 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION"
Regulatory Filings
2021-05-11 English
VOLUNTARY ANNOUNCEMENT - "SORAFENIB TOSYLATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2021-05-11 English
VOLUNTARY ANNOUNCEMENT - "ALOGLIPTIN BENZOATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2021-05-11 English
VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL FIRST-IN-CLASS PRODUCT SYSA1801 GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA
Regulatory Filings
2021-05-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2021
Regulatory Filings
2021-05-03 English
CONNECTED TRANSACTION - DISPOSAL OF 49.5% EQUITY INTEREST IN JOINT VENTURE COMPANY /CONTINUING CONNECTED TRANSACTIONS - MASTER PURCHASE AGREEMENT
Regulatory Filings
2021-04-30 English
INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2021
Interim / Quarterly Report
2021-04-26 English
VOLUNTARY ANNOUNCEMENT - NBL-012 OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Regulatory Filings
2021-04-23 English
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR MARKETING APPROVAL OF "DUVELISIB CAPSULES" ACCEPTED BY NMPA
Regulatory Filings
2021-04-19 English
PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, 18 MAY 2021 AT 10:00 A.M. (AND AT ANY ADJOURNMENT THEREOF)
Proxy Solicitation & Information Statement
2021-04-14 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2021-04-14 English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS: NOTICE OF PUBLICATION OF 2020 ANNUAL REPORT AND THE CIRCULAR DATED 15 APRIL 2021
Report Publication Announcement
2021-04-14 English
PROPOSALS FOR GENERAL MANDATES TO BUY-BACK SHARES AND TO ISSUE SHARES AND MANDATE TO GRANT OPTIONS, RE-ELECTION OF THE RETIRING DIRECTORS, AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2021-04-14 English
2020 ANNUAL REPORT
Regulatory Filings
2021-04-14 English
INVESTIGATIONAL NEW DRUG NBL-015 GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA
Regulatory Filings
2021-04-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2021
Major Shareholding Notification
2021-04-01 English
VOLUNTARY ANNOUNCEMENT - "AMPHOTERICIN B CHOLESTERYL SULFATE COMPLEX FOR INJECTION" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2021-04-01 English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PHASE I CLINICAL TRIAL OF "DOCETAXEL FOR INJECTION (ALBUMIN-BOUND)"
Regulatory Filings
2021-03-30 English
VOLUNTARY ANNOUNCEMENT - JMT601 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.
Regulatory Filings
2021-03-29 English
VOLUNTARY ANNOUNCEMENT - JMT601 OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Regulatory Filings
2021-03-25 English
VOLUNTARY ANNOUNCEMENT - DUAL INHIBITOR JAK-SyK "SYHX1901" OBTAINS CLINICAL TRIAL APPROVAL
Regulatory Filings
2021-03-16 English
ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020
Annual Report
2021-03-15 English
VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND COMMERCIALIZATION AGREEMENT
Capital/Financing Update
2021-03-10 English
VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND COMMERCIALIZATION AGREEMENT
Capital/Financing Update
2021-03-09 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2021-03-09 English
APPOINTMENT AND RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTORS
Board/Management Information
2021-03-05 English
POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 5 MARCH 2021
Declaration of Voting Results & Voting Rights Announcements
2021-03-05 English
INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 December 2020
Annual Report
2021-03-04 English
DATE OF BOARD MEETING
Regulatory Filings
2021-03-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2021
Major Shareholding Notification
2021-03-01 English
PROXY FORM FOR USE FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, 5 MARCH 2021 AT 10:00 A.M. (AND AT ANY ADJOURNMENT THEREOF)
Proxy Solicitation & Information Statement
2021-02-07 English
NOTICE OF 2021 FIRST EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2021-02-07 English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS: NOTICE OF PUBLICATION OF THE CIRCULAR DATED 8 FEBRUARY 2021
Report Publication Announcement
2021-02-07 English
PROPOSED DOMESTIC ISSUE UNDER SPECIFIC MANDATE, PROPOSED AMENDMENTS TO ARTICLES OF ASSOCIATION, RE-ELECTION OF DIRECTORS AND NOTICE OF THE EGM
Proxy Solicitation & Information Statement
2021-02-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2021
Major Shareholding Notification
2021-02-02 English
PROPOSED ISSUE OF RMB SHARES UNDER SPECIFIC MANDATE PROPOSED AMENDMENTS TO ARTICLES OF ASSOCIATION
Capital/Financing Update
2021-02-01 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2021-01-27 English
APPOINTMENT AND RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND CHANGE OF BOARD COMMITTEE S
Board/Management Information
2021-01-27 English
VOLUNTARY ANNOUNCEMENT - NBL-012 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.
Regulatory Filings
2021-01-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2020
Regulatory Filings
2021-01-04 English